Throughout the last three months, 11 analysts have evaluated Jazz Pharmaceuticals (NASDAQ:JAZZ), offering a diverse set of opinions from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 4 | 4 | 3 | 0 | 0 |
Last 30D | 2 | 4 | 1 | 0 | 0 |
1M Ago | 0 | 0 | 2 | 0 | 0 |
2M Ago | 2 | 0 | 0 | 0 | 0 |
3M Ago | 0 | 0 | 0 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for Jazz Pharmaceuticals, presenting an average target of $163.73, a high estimate of $210.00, and a low estimate of $113.00. A 4.25% drop is evident in the current average compared to the previous average price target of $171.00.
Analyzing Analyst Ratings: A Detailed Breakdown
A comprehensive examination...
ログインすると全部閲覧できます。
ログイン